We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
11401
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$91K ﹤0.01%
1,621
+1,213
+297% +$66.3K
TRVN
11402
CALL
DELISTED
Trevena, Inc.
TRVN
$91K ﹤0.01%
350
+45
+15% +$9.9K
OIG
11403
CALL
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$91K ﹤0.01%
3,630
+1,375
+61% +$60.9K
BOXD
11404
DELISTED
Boxed, Inc.
BOXD
$91K ﹤0.01%
49,487
+32,525
+192% +$251K
TGA
11405
CALL
DELISTED
Transglobe Energy Corp
TGA
$91K ﹤0.01%
+26,800
New +$115K
THER
11406
DELISTED
THERATECHNOLOGIES INC COM
THER
$91K ﹤0.01%
40,112
+25,955
+183% +$58.9K
AROC icon
11407
CALL
Archrock
AROC
$6.08B
$90K ﹤0.01%
10,900
-15,600
-59% -$143K
MCRB icon
11408
CALL
Seres Therapeutics
MCRB
$45.6M
$90K ﹤0.01%
1,305
-1,085
-45% -$93.5K
PGRU
11409
DELISTED
PropertyGuru Group Limited
PGRU
$90K ﹤0.01%
20,039
-31,623
-61% -$200K
SPPI
11410
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$90K ﹤0.01%
115,700
+30,200
+35% +$26.6K
EVFM
11411
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$90K ﹤0.01%
79,208
+66,008
+500% +$109K
ARBE icon
11412
CALL
Arbe Robotics
ARBE
$97.8M
$89K ﹤0.01%
+16,200
New +$110K
CNBS icon
11413
CALL
Amplify Seymour Cannabis ETF
CNBS
$76.5M
$89K ﹤0.01%
1,125
INOD icon
11414
Innodata
INOD
$2.09B
$89K ﹤0.01%
+18,272
New +$118K
NGD
11415
CALL
DELISTED
New Gold Inc
NGD
$89K ﹤0.01%
82,900
+16,100
+24% +$23K
RETL icon
11416
CALL
Direxion Daily Retail Bull 3X ETF
RETL
$27.3M
$89K ﹤0.01%
11,900
-3,100
-21% -$41.6K
KLRS
11417
CALL
Kalaris Therapeutics
KLRS
$97.1M
$89K ﹤0.01%
+987
New +$103K
MCBC
11418
DELISTED
Macatawa Bank Corp
MCBC
$89K ﹤0.01%
+10,033
New +$89.6K
TRAQ.WS
11419
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$89K ﹤0.01%
597,050
-278,443
-32% -$64.5K
ALZN icon
11420
Alzamend Neuro
ALZN
$7.43M
$88K ﹤0.01%
+75
New +$97.2K
AROC icon
11421
PUT
Archrock
AROC
$6.08B
$88K ﹤0.01%
+10,700
New +$98K
IMTX icon
11422
PUT
Immatics
IMTX
$1.29B
$88K ﹤0.01%
+10,100
New +$79.9K
KLTR icon
11423
Kaltura
KLTR
$249M
$88K ﹤0.01%
44,188
-136,067
-75% -$233K
LGMK
11424
CALL
DELISTED
LogicMark
LGMK
$88K ﹤0.01%
162
-39
-19% -$29K
NURO
11425
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$88K ﹤0.01%
+3,006
New +$89.7K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.